Given more complicated genomic and transcriptomic landscapes were profiled for LCNEC,20 its intermediate features have posed a challenge to the previous classification criteria simply based on TP53 and RB1 co‐mutations. This evidence concerns the gene TP53 and large cell neuroendocrine carcinoma.